Real Time Touch



new TOP 200 Companies filing patents this week

new Companies with the Most Patent Filings (2010+)




Real Time Touch

Fidia Farmaceutici S p a patents


Recent patent applications related to Fidia Farmaceutici S p a. Fidia Farmaceutici S p a is listed as an Agent/Assignee. Note: Fidia Farmaceutici S p a may have other listings under different names/spellings. We're not affiliated with Fidia Farmaceutici S p a, we're just tracking patents.

ARCHIVE: New 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 | Company Directory "F" | Fidia Farmaceutici S p a-related inventors


Sulphated hyaluronic acids as regulator agents of the cytokine activity

The object of the present invention relates to the new and surprising use of sulfated hyaluronic acid (HAS) as regulator agent of the cytokine activity (pro- and antiinflammatory) and consequently the use of HAS for the preparation of a new medicine for the prevention and treatment of pathologies associated with... Fidia Farmaceutici S p a

New process for the production and purification of the collagenase enzyme from vibrio alginolyticus

The present invention claims a novel process for the production and purification of microbial collagenase (Microbial Collagenase EC 3.4.24.3) produced by the non-pathogenic aerobic bacterium Vibrio alginolyticus chemovar. iophagus (NCIMB Number: 11038, synonym LMG 3418, hereinafter called Vibrio alginolyticus), which said process provides high production levels of collagenase with a... Fidia Farmaceutici S p a

Derivatives obtained from hyaluronic acid and carnosine

The present invention relates to a derivative of carnosine (β-alanyl-L-histidine) having formula (1), obtained by the functionalization of hyaluronic acid with carnosine.... Fidia Farmaceutici S p a

Dermal therapeutic system with high adhesivity

The present invention relates to a high adhesion dermal therapeutic system comprising an adhesive polymeric matrix with a salt of Diclofenac.... Fidia Farmaceutici S p a

Pharmaceutical formulations comprising chondroitin sulfate and hyaluronic acid derivatives

The present invention relates to pharmaceutical formulations containing a combination of specific high-molecular weight hyaluronic acid derivatives and chondroitin sulfate to be used in the treatment of osteoarthritis, of subchondral damage, osteoporosis, synovitis, tenosynovitis, tendinitis, tendinosis, as an intra-articular washing liquid and as a viscous substitute of synovial fluid following... Fidia Farmaceutici S p a

Pharmaceutical compositions containing hyaluronic acid and collagenase for the topical treatment of wounds, burns and ulcers

The present invention concerns new compositions containing hyaluronic acid or the derivatives thereof in association with the proteolytic enzyme collagenase (and relative pharmaceutical formulations) for the preparation of a dressing for topical treatment of various kinds of wounds, burns of varying depth, pressure sores, vascular ulcers and diabetic foot ulcers... Fidia Farmaceutici S p a

Medicines for topic use based on sulfated hyaluronic acid as activating or inhibiting agent of the cytokine activity

The object of the present invention relates to the new and surprising use of sulfated hyaluronic acid (HAS) as regulator agent of the cytokine activity (pro- and anti-inflammatory) and consequently the use of HAS for the preparation of a new medicine for topic use in the prevention and treatment of... Fidia Farmaceutici S p a

Extracellular hyaluronidase from streptomyces koganeiensis

A process for preparing Streptomyces koganeiensis ATCC 31394 hyaluronidase includes obtaining hyaluronidase having molecular weight of 21.6 kDalton, which has hyaluronidase activity and stability markedly higher than those of the hyaluronidase obtained from such microorganism to date.... Fidia Farmaceutici S p a

Pharmaceutical compositions with hydrating and lubricating activity

The present invention discloses pharmaceutical compositions comprising ester derivatives of hyaluronic acid for use as a topical treatment in disorders of the vaginal mucosa characterised by loss of elasticity and hydration, such as vaginal dryness and/or atrophic vaginitis; said compositions can also be used successfully to lubricate the genital mucosa.... Fidia Farmaceutici S p a








ARCHIVE: New 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009



###

This listing is an abstract for educational and research purposes is only meant as a recent sample of applications filed, not a comprehensive history. Freshpatents.com is not affiliated or associated with Fidia Farmaceutici S p a in any way and there may be associated servicemarks. This data is also published to the public by the USPTO and available for free on their website. Note that there may be alternative spellings for Fidia Farmaceutici S p a with additional patents listed. Browse our Agent directory for other possible listings. Page by FreshPatents.com

###